Proquin XR Related Published Studies
Well-designed clinical trials related to Proquin XR (Ciprofloxacin)
Ciprofloxacin or metronidazole for the treatment of perianal fistulas in patients with Crohn's disease: A randomized, double-blind, placebo-controlled pilot study. [2008.07.30]
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy. [2008.07]
Assessment of bioequivalence of ciprofloxacin in healthy male subjects using HPLC. [2008.07]
Ciprofloxacin in primary prophylaxis of spontaneous bacterial peritonitis: a randomized, placebo-controlled study. [2008.05]
Ocular penetration of levofloxacin, ofloxacin and ciprofloxacin in eyes with functioning filtering blebs: investigator masked, randomised clinical trial. [2008.03]
Ciprofloxacin and furagin in acute cystitis: comparison of early immune and microbiological results. [2008.02]
A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis. [2008.01]
Pharmacokinetics of topically applied ciprofloxacin in equine tears. [2007.11]
Effects of lanthanum carbonate on the absorption and oral bioavailability of ciprofloxacin. [2007.11]
A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis. [2007.11]
Oral ciprofloxacin or trimethoprim reduces bacteriuria after flexible cystoscopy. [2007.10]
Ciprofloxacin prolonged-release tablets do not affect warfarin pharmacokinetics and pharmacodynamics. [2007.10]
Bioequivalence evaluation of two different formulations of ciprofloxacin tablets in healthy volunteers. [2007.09]
Bioequivalence of ciprofloxacin tablet formulations assessed in Indonesian volunteers. [2007.06]
A comparison of ciprofloxacin/dexamethasone with neomycin/polymyxin/hydrocortisone for otitis externa pain. [2007.05]
Role of ciprofloxacin in patients with cholestasis after endoscopic retrograde cholangiopancreatography. [2007.01.14]
Effect of Five Alive fruit juice on the dissolution and absorption profiles of ciprofloxacin. [2007.01]
Effects of paracetamol on the pharmacokinetics of ciprofloxacin in plasma using a microbiological assay. [2007]
Urinary bactericidal activity of extended-release ciprofloxacin (1,000 milligrams) versus levofloxacin (500 milligrams) in healthy volunteers receiving a single oral dose. [2006.11]
Addition of inhaled tobramycin to ciprofloxacin for acute exacerbations of Pseudomonas aeruginosa infection in adult bronchiectasis. [2006.11]
One week of ciprofloxacin before percutaneous nephrolithotomy significantly reduces upper tract infection and urosepsis: a prospective controlled study. [2006.11]
Topical ciprofloxacin/dexamethasone superior to oral amoxicillin/clavulanic acid in acute otitis media with otorrhea through tympanostomy tubes. [2006.09]
Comparison of sequential intravenous/oral ciprofloxacin plus metronidazole with intravenous ceftriaxone plus metronidazole for treatment of complicated intra-abdominal infections. [2006.08]
Effectiveness of ciprofloxacin prophylaxis in preventing bacteriuria caused by urodynamic study: a blind, randomized study of 192 patients. [2006.06]
A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. [2006.06]
Effect of omeprazole on bioavailability of an oral extended-release formulation of ciprofloxacin. [2006.04.01]
Ciprofloxacin as a representative of disk diffusion in vitro susceptibility of enrofloxacin for bacterial organisms from the middle-ear tissue of dogs with end-stage otitis externa. [2006.04]
Comparison of topical gatifloxacin 0.3% and ciprofloxacin 0.3% for the treatment of bacterial keratitis. [2006.02]
Switch therapy with ciprofloxacin vs. intravenous ceftazidime in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis: similar efficacy at lower cost. [2006.01.01]
Pharmacokinetics of ciprofloxacin XR (1000mg) versus levofloxacin (500mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose. [2006.01]
Oral ciprofloxacin affects the pharmacokinetics of paracetamol in saliva. [2006]
Pharmacokinetics and pharmacodynamics of a novel extended-release ciprofloxacin in healthy volunteers. [2005.11]
Single-dose ciprofloxacin versus 12-dose erythromycin for childhood cholera: a randomised controlled trial. [2005.09.24]
Ciprofloxacin suppresses bacterial overgrowth, increases fasting insulin but does not correct low acylated ghrelin concentration in non-alcoholic steatohepatitis. [2005.08.15]
Plasma and interstitial fluid pharmacokinetics of enrofloxacin, its metabolite ciprofloxacin, and marbofloxacin after oral administration and a constant rate intravenous infusion in dogs. [2005.08]
Single-dose oral ciprofloxacin compared with single-dose intravenous cefazolin for prophylaxis in inguinal hernia repair: a controlled randomized clinical study. [2005.08]
Effect of simulated microgravity on the disposition and tissue penetration of ciprofloxacin in healthy volunteers. [2005.07]
Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen. [2005.07]
The role of ciprofloxacin in prolonging polyethylene biliary stent patency: a multicenter, double-blinded effectiveness study. [2005.04]
Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances. [2005.04]
Penetration of topically applied gatifloxacin 0.3%, moxifloxacin 0.5%, and ciprofloxacin 0.3% into the aqueous humor. [2005.03]
Amoxicillin-clavulanate vs ciprofloxacin for the treatment of uncomplicated cystitis in women: a randomized trial. [2005.02.23]
Prulifloxacin versus ciprofloxacin in the treatment of adults with complicated urinary tract infections. [2005]
Well-designed clinical trials possibly related to Proquin XR (Ciprofloxacin)
A randomized prospective trial of endoscopic ultrasound to guide combination medical and surgical treatment for Crohn's perianal fistulas. [2008.10]
Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder. [2008.09]
Extended-Release Metformin Does Not Reduce the Clomiphene Citrate Dose Required to Induce Ovulation in Polycystic Ovary Syndrome. [2008.08]
Topical ciprofloxin versus topical framycetin-gramicidin-dexamethasone in Australian aboriginal children with recently treated chronic suppurative otitis media: a randomized controlled trial. [2008.08]
Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR. [2008.07.17]
Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. [2008.07]
Validation of a reversed-phase high-performance liquid chromatography method with fluorescence detection for the bioequivalence study of norfloxacin in plasma samples. [2008.06]
Does disposable needle guide minimize infectious complications after transrectal prostate needle biopsy? [2008.06]
A double-blind comparison of sexual functioning, antidepressant efficacy, and tolerability between agomelatine and venlafaxine XR. [2008.06]
A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam. [2008.05.21]
Effect of the Antidepressant Venlafaxine in Functional Dyspepsia: A Randomized, Double-Blind, Placebo-Controlled Trial. [2008.04.17]
An investigation of the effect of immediate and extended release venlafaxine on nocturnal melatonin and cortisol release in healthy adult volunteers. [2008.03]
Randomized trial of combination versus monotherapy for the empiric treatment of suspected ventilator-associated pneumonia. [2008.03]
Correlates of clinical failure in ventilator-associated pneumonia: insights from a large, randomized trial. [2008.03]
Adjuvant interferon gamma in patients with pulmonary atypical Mycobacteriosis: a randomized, double-blind, placebo-controlled study. [2008.02.11]
Pharmacokinetic-pharmacodynamic integration of orbifloxacin in rabbits after intravenous, subcutaneous and intramuscular administration. [2008.02]
Early treatment response in alcohol dependence with extended-release naltrexone. [2008.02]
Is surface roughness of resin composites affected by operator's performance? [2008.02]
Fracture resistance of endodontically treated teeth restored with combined composite-amalgam restorations. [2008.02]
Fluoroquinolones for treating tuberculosis. [2008.01.23]
Early Treatment Response in Alcohol Dependence With Extended-Release Naltrexone. [2008.01.09]
Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. [2008]
Similar bioavailability of dexmethylphenidate extended (bimodal) release, dexmethyl-phenidate immediate release and racemic methylphenidate extended (bimodal) release formulations in man. [2007.12]
Ototoxicity of Topical Moxifloxacin in a Chinchilla Animal Model. [2007.12]
Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder. [2007.11.29]
Lisdexamfetamine dimesylate and mixed amphetamine salts extended-release in children with ADHD: a double-blind, placebo-controlled, crossover analog classroom study. [2007.11.01]
Bioequivalence evaluation of 320 mg gemifloxacin tablets in healthy volunteers. [2007.11]
Efficacy of extended-release naltrexone in alcohol-dependent patients who are abstinent before treatment. [2007.10]
Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. [2007.10]
[Acute cystitis in women with type 2 diabetes. Three antimicrobial schemes] [2007.09]
[Effectiveness of switch therapy for peritonitis] [2007.08]
Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD. [2007.07]
Topical diclofenac versus dexamethasone after strabismus surgery: A double-blind randomized clinical trial of anti-inflammatory effect and ocular hypertensive response. [2007.07]
Efficacy and tolerability of once-daily extended release quetiapine fumarate in acute schizophrenia: a randomized, double-blind, placebo-controlled study. [2007.06]
Short-term antibiotic prophylaxis in implant surgery: a comparison of three antibiotics. [2007.06]
Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran co-administered with different classes of antibiotics in healthy volunteers. [2007.06]
Duloxetine as an SNRI treatment for generalized anxiety disorder: results from a placebo and active-controlled trial. [2007.05]
Cognitive, psychomotor and actual driving performance in healthy volunteers after immediate and extended release formulations of alprazolam 1 mg. [2007.05]
The evaluation of direct composite restorations for the worn mandibular anterior dentition - clinical performance and patient satisfaction. [2007.05]
On the effect of an internal light conductor on the marginal integrity of class-II composite fillings. [2007.02]
Current approaches to the pharmacologic treatment of anxiety disorders. [2007]
Paederus dermatitis in Sierra Leone. [2006.12.10]
Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder. [2006.12]
The combined effects of alpha-tocopheryl acetate supplementation and enrofloxacin administration on oxidative stability of turkey meat. [2006.12]
Outcome of cephalosporin treatment of bacteremia due to CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli. [2006.12]
A randomized, double-blind, active-control study of sertraline versus venlafaxine XR in major depressive disorder. [2006.11]
A double-blind comparison between bupropion XL and venlafaxine XR: sexual functioning, antidepressant efficacy, and tolerability. [2006.10]
A pilot study on prevention of catheter-related urinary tract infections with fluoroquinolones. [2006.10]
A comparison of the efficacy and tolerability of reboxetine and sertraline versus venlafaxine in major depressive disorder: a randomized, open-labeled clinical trial. [2006.09.30]
Pharmacokinetics of an extended release formulation of alprazolam (Xanax XR) in healthy normal adolescent and adult volunteers. [2006.09]
Escitalopram versus venlafaxine XR in the treatment of depression. [2006.09]
Mixed amphetamine salts extended-release in the treatment of adult ADHD: a randomized, controlled trial. [2006.08]
A clinical evaluation of posterior composite restorations: 17-year findings. [2006.08]
Comparison of efficacy and tolerability of reboxetine and venlafaxine XR in major depression and major depression with anxiety features: an open label study. [2006.07]
Single-dose azithromycin for the treatment of cholera in adults. [2006.06.08]
Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder. [2006.06]
Fourth-generation fluoroquinolone penetration into the aqueous humor in humans. [2006.06]
Single-dose intravenous and oral pharmacokinetics of enrofloxacin in goral (Nemorrhaedus goral arnouxianus). [2006.06]
|
